NEOGEN Neogen Chemicals Q2 FY26 results (Jul–Sep 2025) and concall
Neogen Chemicals reported an 8% YoY revenue growth to ₹209 crore in Q2 FY26, with gross profit up 16% and PAT at ₹3 crore, impacted by elevated operating costs and finance charges. The company is progressing with its battery chemicals expansion, with the Dahej plant approved for electrolyte supply by a key Indian customer and provisional approval for lithium electrolyte salt from an international customer. Delays in Indian gigafactory ramp-up and final salt approvals have shifted commercial production timelines for battery chemicals to H1/H2 FY27, but the company remains confident in achieving
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|
| Revenue | 22 | -3 | 5 | 7 |
| EBITDA | 38 | 41 | 35 | 35 |
| Net profit | 14 | 5 | 14 | 9 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
